First isolated and characterized over 60 years ago, strains of Bifidobacterium bifidum have been extensively studied and many characterized in detail at a molecular level over the subsequent decades. Several properties of potential clinical significance have been identified in the laboratory: immune-modulatory, metabolic, antibacterial, and antiviral. Clinical trials in man have revealed positive effects in diarrheal disease, disorders involving mucosal inflammation of the gastrointestinal tract, and functional gastrointestinal disorders.

Original languageEnglish (US)
Title of host publicationThe Microbiota in Gastrointestinal Pathophysiology
Subtitle of host publicationImplications for Human Health, Prebiotics, Probiotics, and Dysbiosis
Number of pages3
ISBN (Electronic)9780128040621
ISBN (Print)9780128040249
StatePublished - Jan 1 2017


  • BGN4 and PRL 2010
  • Bacteriocin
  • BbVK3
  • Bifidobacterium bifidum
  • Bifidobacterium bifidum strains BB-06
  • Diarrhea
  • G9-1
  • Genome
  • Immunity
  • Irritable bowel syndrome
  • Mimbb-75
  • NCFB 1454
  • Pilus
  • R0071
  • YIT 4007
  • YIT-10347

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Bifidobacterium bifidum'. Together they form a unique fingerprint.

Cite this